Long term oxygen therapy( LTOT) is the administration of oxygen to increase survival and quality of life in hypoxemic patients with COPD as a medical intervention for both chronic and acute patient care. Patients having high blood carbon dioxide and emphysema may reduce respiratory drive in LTOT.
It also appears to reduce the number of hospitalizations, increase effort capacity, and improve health-related quality of life. Standard LTOT criteria are related to COPD patients who have PaO2 <60 mmHg, are in a clinical stable situation, and are receiving optimal pharmacological treatment. According to LTOT guidelines, oxygen should be prescribed for at least 18 hours per day.
Related Journals of Long Term Oxygen Therapy
Pulmonary & Respiratory Medicine, Experimental Lung Research, Multidisciplinary Respiratory Medicine, Open Respiratory Medicine Journal, Paediatric Respiratory Reviews, Primary Care Respiratory Journal.
4th International Conference on Chronic Obstructive Pulmonary Disease
May 29-31, 2017, Osaka, Japan
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : April 27, 2017